RecruitingNot applicableNCT06442319

The Efficiency and Safety of PRP Treatment After Anterior Cruciate Ligament Reconstruction.

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nicolaus Copernicus University in Toruń, Collegium Medicum in Bydgoszcz
Intervention
Platelet-rich plasma(biological)
Enrollment
60 target
Eligibility
18-45 years · All sexes
Timeline
20242030

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06442319 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials